These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9562060)

  • 1. MRI of the liver.
    Laing AD; Gibson RN
    J Magn Reson Imaging; 1998; 8(2):337-45. PubMed ID: 9562060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast agents used in MR imaging of the liver.
    Karabulut N; Elmas N
    Diagn Interv Radiol; 2006 Mar; 12(1):22-30. PubMed ID: 16538580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of the liver.
    Larson RE; Semelka RC
    Top Magn Reson Imaging; 1995; 7(2):71-81. PubMed ID: 7772372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of focal and diffuse hepatic disease.
    Siegelman ES; Outwater EK
    Semin Ultrasound CT MR; 1998 Feb; 19(1):2-34. PubMed ID: 9503518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hepatocyte-specific staining in liver pathology.
    Filippone A; Cianci R; Patriarca G; Sabatino F; Tartaro A; Cotroneo AR
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):353-63. PubMed ID: 21651353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of the liver.
    Vassiliades VC; Bernardino ME
    Top Magn Reson Imaging; 1990 Jun; 2(3):1-16. PubMed ID: 2161245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of magnetic resonance imaging in liver pathology].
    Mathieu D; Jazaerli N; Paret M; Kobeiter H
    Rev Prat; 1996 Apr; 46(7):817-23. PubMed ID: 8761741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of diseases of the liver and biliary system.
    Kanzer GK; Weinreb JC
    Radiol Clin North Am; 1991 Nov; 29(6):1259-84. PubMed ID: 1947045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of MRI in diagnosis of focal liver lesions].
    Taupitz M; Hamm B
    Radiologe; 1995 Nov; 35(11 Suppl 2):S243-7. PubMed ID: 8588028
    [No Abstract]   [Full Text] [Related]  

  • 11. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of diffuse liver disease: from technique to diagnosis.
    Hope TA; Ohliger MA; Qayyum A
    Radiol Clin North Am; 2014 Jul; 52(4):709-24. PubMed ID: 24889168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of the liver. A pictorial essay.
    Shapiro RS; Glajchen N; Stancato-Pasik A
    Clin Imaging; 1997; 21(4):293-302. PubMed ID: 9215480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion and perfusion imaging of the liver.
    Chandarana H; Taouli B
    Eur J Radiol; 2010 Dec; 76(3):348-58. PubMed ID: 20399054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Overview of MRI contrast media. The case of endorem].
    Duroux M
    Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance imaging. Liver-specific contrast agents.
    Ji H; Ros PR
    Clin Liver Dis; 2002 Feb; 6(1):73-90. PubMed ID: 11933597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
    Dobritz M; Radkow T; Nittka M; Bautz W; Fellner FA
    Rofo; 2002 Jun; 174(6):738-41. PubMed ID: 12063604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal liver lesion detection and characterization with GD-EOB-DTPA.
    Purysko AS; Remer EM; Veniero JC
    Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of diffuse liver disease.
    Mortele KJ; Ros PR
    Semin Liver Dis; 2001 May; 21(2):195-212. PubMed ID: 11436572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging (MRI) and diseases of the liver and biliary tract. Part 1. Basic principles, MRI in the assessment of diffuse and focal hepatic disease.
    Macdonald GA; Peduto AJ
    J Gastroenterol Hepatol; 2000 Sep; 15(9):980-91. PubMed ID: 11059926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.